Skip to content

Abnormal Placenta Plant Disease Early Diagnosis and Individualized Treatment Research

Abnormal Placenta Plant Disease Early Diagnosis and Individualized Treatment Research

Status
UNKNOWN
Phases
Unknown
Study type
Observational
Source
ClinicalTrials.gov
Registry ID
NCT02946749
Enrollment
3000
Registered
2016-10-27
Start date
2016-12-31
Completion date
2018-12-31
Last updated
2017-08-01

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Scarred Uterus

Keywords

Scar pregnancy, Placenta planting abnormal disease, Early diagnosis, Individualized treatment

Brief summary

As the two-child policy implementation, caesarean women's clinical pregnancy is a huge problem again, Especially the placenta planting abnormal disease is a serious threat to the maternal health and life. Through this research, the investigators can obtain relevant epidemiological data and provide objective data for the department of public health policy; Predicting an placenta abnormal planting early diagnosis model was constructed, it will fill the blank in this field, and high-risk groups in the early stages of pregnancy will be taken proper disposal, the related complications will be reduced to ensure the safety of maternal.

Detailed description

This study focus on four hands: (1) to investigate different types of gestational sac implantation for pregnancy in caesarean women of childbearing age;(2) to explore the relationship between abnormal placenta planting disease in middle-late pregnancy and the different types of scar pregnancy (3) to explore the the value of ultrasound and serological markers for early diagnosis of placenta planting disease from scar pregnancy; (4) to compare the end and the influence of health economy of different termination method on scar pregnancy.

Interventions

None listed

Sponsors

Shanghai First Maternity and Infant Hospital
Lead SponsorOTHER

Study design

Observational model
COHORT
Time perspective
PROSPECTIVE

Eligibility

Sex/Gender
FEMALE
Age
18 Years to 45 Years
Healthy volunteers
Yes

Inclusion criteria

* Single pregnancies with once cesarean section history * see a doctor before gestational 8 weeks in our study center * will continue to pregnancy, high patient compliance

Exclusion criteria

* twins or multiple pregnancies * hysteromyoma or adenomyoma stripping history * history of intrauterine adhesions

Design outcomes

Primary

MeasureTime frame
Placenta implantedup to 37 gestational weeks

Secondary

MeasureTime frame
Placenta previaup to 37 gestational weeks

Contacts

Primary ContactHao Ying, PHD
stephenying2011@126.com13371985049
Backup ContactChuanlu Xu, Master
xuchuanlu@foxmail.com13661631960

Outcome results

None listed

Source: ClinicalTrials.gov · Data processed: Feb 4, 2026